is a non-profit research organization founded by Silicon Valley investor Sam Altman and billionaire Elon Musk, whose funders include venture capitalist Peter Thiel.
Although there is no cure for Alzheimer's, the researchers say therapeutic options exist if the disease is spotted early. With help from the U.S National Institutes of Health, researchers say they trained the program using transcripts from, gathered specifically to test the ability of natural language processing programs to predict dementia.
The program also performed better in predicting the severity of a person's dementia compared to an "acoustic" analysis that looked at features such as pauses, voice strength and slurring.